Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-02
1998-09-29
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142378, 514255, 514315, 514611, 546244, 548557, 564 81, 564113, 544164, 544382, A61K 3140, A61K 31535, A61K 31495, A61K 31445
Patent
active
058146563
ABSTRACT:
A method for the treatment of mammalian tissue injured or at risk of injury during sepsis or shock including the administration to a mammal a diazeniumdiolate which releases a therapeutically effective amount of nitric oxide sufficient to protect the tissue from sepsis- or shock-induced injury.
REFERENCES:
patent: 5366997 (1994-11-01), Keefer et al.
Keefer Larry K.
Saavedra Joseph E.
Henley III Raymond
The United States Of America, as represented by the Department O
LandOfFree
Selective prevention of organ injury is sepsis and shock using s does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective prevention of organ injury is sepsis and shock using s, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective prevention of organ injury is sepsis and shock using s will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-686717